WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
0.04 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100590 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
1.49 |
ml/min |
0.09 |
0.2 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100597 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
0.16 |
nl/(s x mmHg) |
0.05 |
0.1 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100617 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
67.0 |
nl/min |
13.0 |
29.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
sngfr |
100608 |
2479 |
WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
0 days
| 6 |
186.0 |
nl/min |
17.0 |
41.64 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
afferent arteriolar plasma flow rate |
100528 |
2479 |
WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
1.25 |
ml/min |
0.09 |
0.25 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100459 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
65.0 |
nl/min |
9.0 |
20.12 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
sngfr |
100610 |
2479 |
WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) (for 0.5 hours) then saralasin (0.3 mg/kg/hr) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
0 days
| 5 |
314.0 |
nl/min |
34.0 |
76.03 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
qa |
100613 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 6 |
17.0 |
nl/min |
2.0 |
4.9 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
sngfr |
100518 |
2479 |
WKY |
glomerular capillary hydraulic pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
0 days
| 9 |
68.0 |
mmHg |
2.0 |
6.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
pgc |
100535 |
2479 |
WKY |
glomerular capillary hydraulic pressure |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
0 days
| 8 |
46.0 |
mmHg |
2.0 |
5.66 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
pgc |
100536 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then 0.9% sodium chloride solution (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
57.0 |
nl/min |
8.0 |
17.89 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
sngfr |
100611 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
0.11 |
nl/(s x mmHg) |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100591 |
2479 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 5 |
0.94 |
ml/min |
0.11 |
0.25 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
70 |
days |
|
101206 |
2581 |
WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
1.43 |
ml/min |
0.09 |
0.27 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
100462 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
82.0 |
nl/min |
10.0 |
22.36 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
sngfr |
100609 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
1.24 |
ml/min |
0.07 |
0.16 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100598 |
2479 |
WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
0 days
| 5 |
270.0 |
nl/min |
44.0 |
98.39 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
qa |
100612 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
0.06 |
nl/(s x mmHg) |
0.02 |
0.04 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
0 |
|
kf |
100616 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 7 |
0.31 |
ml/min |
0.05 |
0.13 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
100455 |
2479 |
WKY |
glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
0.38 |
ml/min |
0.08 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
|
100456 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
1.28 |
ml/min |
0.06 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100458 |
2479 |
WKY |
single nephron glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 9 |
50.0 |
nl/min |
3.0 |
9.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
sngfr |
100520 |
2479 |
WKY |
glomerular capillary hydraulic pressure |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
blood molecular composition trait |
male |
0 days
| 6 |
50.0 |
mmHg |
3.0 |
7.35 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
15 |
days |
pgc |
100533 |
2479 |
WKY |
single nephron glomerular filtration rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
61.0 |
nl/min |
3.0 |
8.49 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100521 |
2479 |
WKY |
afferent arteriolar plasma flow rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
0 days
| 9 |
169.0 |
nl/min |
14.0 |
42.0 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
afferent arteriolar plasma flow rate |
100530 |
2479 |
WKY |
glomerular capillary ultrafiltration coefficient |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 6 |
0.02 |
nl/(s x mmHg) |
0.0 |
0.01 |
inulin analysis by liquid phase colorimetry |
glomerular capillary |
0.0 |
PA IV 50mg/kg |
15 |
days |
kf |
100588 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
1.22 |
ml/min |
0.03 |
0.07 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100596 |
2479 |
MW |
glomerular filtration rate |
unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) |
Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. |
glomerular filtration trait |
male |
0 days
| 6 |
0.57 |
ml/min |
0.07 |
0.17 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
unx |
70 |
days |
|
101204 |
2581 |
WKY |
afferent arteriolar plasma flow rate |
controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
kidney plasma flow trait |
male |
0 days
| 8 |
244.0 |
nl/min |
21.0 |
59.4 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
afferent arteriolar plasma flow rate |
100531 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 8 |
1.14 |
ml/min |
0.13 |
0.37 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
490 |
days |
|
100461 |
2479 |
WKY |
glomerular filtration rate |
puromycin aminonucleoside (50 mg/kg) then 0.9% sodium chloride solution (for 0.5 hours) |
Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. |
glomerular filtration trait |
male |
0 days
| 5 |
1.19 |
ml/min |
0.08 |
0.18 |
inulin analysis by liquid phase colorimetry |
|
0.0 |
PA IV 50mg/kg |
0 |
|
|
100599 |
2479 |